Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028.
Burgess, MA; Roszik, J; Van Tine, BA; Hu, J; Schuetze, S; D'Angelo, SP; Attia, S; Priebat, DA; Okuno, SH; Riedel, RF; Davis, LE; Movva, S; Reed, DR; Baker, LH; Reinke, DK; Maki, RG; Patel, S; Tawbi, HA-H; Butterfield, LH
Volume / Issue
Electronic International Standard Serial Number (EISSN)
International Standard Serial Number (ISSN)
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET
Conference Start Date
Conference End Date